Cells were grown in phenol red-free DMEM supplemented with 5% charcoal-stripped (CS) fetal bovine serum (5% CS-DMEM) for 24 h. To determine baseline gene expression, cells were cultured in charcoal-stripped medium for at least 24 h to remove factors that may affect basal signaling. Cells were collected, and total RNA was extracted using the
Quick RNA Mini Prep Kit in accordance with the manufacturer's protocol (Zymo Research, Irvine, CA). The quality and concentration of RNA were determined spectrophotometrically by absorbance at 260 and 280 nm using the NanoDrop ND-1000. Total RNA (1 μg) was reverse-transcribed using the
iScript kit (BioRad, Hercules, CA) and qPCR was performed using
SYBR-green (Bio-Rad Laboratories, Hercules, CA). Cycle numbers of ERK5-ko cells were normalized to β-actin and parental control cells scaled to 1,
n = 3. For patient-derived xenografts, RNA was isolated from tumor pieces using
QIAzol Lysis Reagent (Qiagen, Valencia, CA) and
Quick RNA Mini Prep Kit (Zymo Research, Irvine, CA).
Hoang V.T., Matossian M.D., Ucar D.A., Elliott S., La J., Wright M.K., Burks H.E., Perles A., Hossain F., King C.T., Browning V.E., Bursavich J., Fang F., Del Valle L., Bhatt A.B., Cavanaugh J.E., Flaherty P.T., Anbalagan M., Rowan B.G., Bratton M.R., Nephew K.P., Miele L., Collins-Burow B.M., Martin E.C, & Burow M.E. (2020). ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Frontiers in Oncology, 10, 1164.